TREATMENT OF COGNITIVE IMPAIRMENT USING A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST

Details for Australian Patent Application No. 2003285928 (hide)

Owner DRUGABUSE SCIENCES S.A.S.

Inventors Kusmierek, Jacques

Agent Fisher Adams Kelly

Pub. Number AU-A-2003285928

PCT Number PCT/US2003/0334

PCT Pub. Number WO2004/037783

Priority 60/420,582 22.10.02 US

Filing date 22 October 2003

Wipo publication date 13 May 2004

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/420,582 22.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-A-2003285928

24 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003285929-THYMIDYLATE SYNTHASE POLYMORPHISMS FOR USE IN SCREENING FOR CANCER SUSCEPTIBILITY

2003285927-APPARATUS AND METHOD FOR DOCUMENT READING AND AUTHENTICATION